Intellia Therapeutics Inc’s filing revealed that its Director Bhanji Muna unloaded Company’s shares for reported $2252.0 on Apr 29 ’25. In the deal valued at $8.50 per share,265 shares were sold. As a result of this transaction, Bhanji Muna now holds 19,203 shares worth roughly $0.16 million.
Then, Clark Eliana sold 679 shares, generating $6,104 in total proceeds. Upon selling the shares at $8.99, the EVP, Chief Technical Officer now owns 95,369 shares.
Before that, BASTA JAMES sold 2,572 shares. Intellia Therapeutics Inc shares valued at $23,122 were divested by the EVP, General Counsel at a price of $8.99 per share. As a result of the transaction, BASTA JAMES now holds 111,925 shares, worth roughly $0.94 million.
Wolfe Research upgraded its Intellia Therapeutics Inc [NTLA] rating to an Outperform from a a Peer perform in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. JP Morgan also remained covering NTLA and has decreased its forecast on February 28, 2025 with a “Neutral” recommendation from previously “an Overweight” rating. Goldman revised its rating on February 28, 2025. It rated NTLA as “a Sell” which previously was an “a Neutral”.
Price Performance Review of NTLA
On Monday, Intellia Therapeutics Inc [NASDAQ:NTLA] saw its stock fall -4.52% to $8.44. Over the last five days, the stock has lost -0.47%. Intellia Therapeutics Inc shares have fallen nearly -27.62% since the year began. Nevertheless, the stocks have fallen -62.49% over the past one year. While a 52-week high of $28.18 was reached on 01/07/25, a 52-week low of $5.90 was recorded on 04/07/25. SMA at 50 days reached $8.55, while 200 days put it at $14.87.
Levels Of Support And Resistance For NTLA Stock
The 24-hour chart illustrates a support level at 8.31, which if violated will result in even more drops to 8.18. On the upside, there is a resistance level at 8.69. A further resistance level may holdings at 8.94. The Relative Strength Index (RSI) on the 14-day chart is 52.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.52, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 32.65%. Stochastics %K at 79.12% indicates the stock is a holding.
